Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago

被引：18

作者：

Akpaka P.E. ^{[1
]}

Kissoon S. ^{[1
]}

Swanston W.H. ^{[1
]}

Monteil M. ^{[1
]}

机构：

[1] Department of Paraclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine

来源：

Annals of Clinical Microbiology and Antimicrobials | / 5卷 / 1期

关键词：

Vancomycin; Oxacillin; Methicillin Resistance; Latex Agglutination Test; Antimicrobial Susceptibility Pattern;

D O I：

10.1186/1476-0711-5-16

中图分类号：

学科分类号：

摘要：

Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become increasingly prevalent worldwide since it was first reported in a British hospital. The prevalence however, varies markedly in hospitals in the same country, and from one country to another. We therefore sought to document comprehensively the prevalence and antimicrobial susceptibility pattern of MRSA isolates in Trinidad and Tobago. Methods: All Staphylococcus aureus isolates encountered in routine clinical specimens received at major hospitals in the country between 2000 and 2001 were identified morphologically and biochemically by standard laboratory procedures including latex agglutination test (Staphaurex Plus; Murex Diagnostics Ltd; Dartford, England); tube coagulase test with rabbit plasma (Becton, Dickinson & Co; Sparks, MD, USA), and DNase test using DNase agar (Oxoid Ltd; Basingstoke, Hampshire, England). MRSA screening was performed using Mueller-Hinton agar containing 6 μg oxacillin and 4% NaCl, latex agglutination test (Denka Seiken Co. Ltd, Tokyo, Japan) and E-test system (AB Biodisk, Solna, Sweden). Susceptibility to antimicrobial agents was determined by the modified Kirby Bauer disc diffusion method while methicillin MICs were determined with E-test system. Results: Of 1,912 S. aureus isolates received, 12.8% were methicillin (oxacillin) resistant. Majority of the isolates were recovered from wound swabs (86.9%) and the least in urine (0.4%) specimens. Highest number of isolates was encountered in the surgical (62.3%) and the least from obstetrics and gynaecology (1.6%) facilities respectively. Large proportions of methicillin sensitive isolates are >85% sensitive to commonly used and available antimicrobials in the country. All MRSA isolates were resistant to ceftriaxone, erythromycin, gentamicin and penicillin but were 100% sensitive to vancomycin, rifampin and chloramphenicol. Conclusion: There is a progressive increase in MRSA prevalence in the country but the present rate is still low in comparison to values in some other countries. Vancomycin is still the drug of choice for treating multidrug resistant MRSA infections. Further use of molecular studies to monitor the epidemiology of MRSA in these hospitals in the country is highly recommended too. © 2006 Akpaka et al; licensee BioMed Central Ltd.

引用

共 37 条

[21]

Saravolatz L.D., Markowitz N., Arking L., Pohlod D., Fisher E., Methicillin resistant Stophylococcus aureus: Epidemiologic Observations During a Community-Acquired Outbreak, Ann Intern Medicine, 92, 1, pp. 11-16, (1982)

[22]

Charlebois E.D., Bangsberg D.R., Moss N.J., Moore M.R., Moss A.R., Chambers H.F., Perdreau-Remington F., Population-Based Community Prevalence of Methicillin-resistant Staphylococcus aureus in the Urban Poor of San Francisco, Clin Infect Dis, 34, pp. 425-433, (2002)

[23]

Osmon S., Ward S., Fraser V.J., Kollef M.H., Hospital Mortality for Patients with Bacteremia due to Stophylococcus aureus or Pseudomonas aeruginosa, Chest, 125, pp. 607-616, (2004)

[24]

Simor A.E., Ofner-Agostini M., Bryce E., Green K., McGee A., Mulvey A., Paton S., Evolution of methicillin-resistant Stophylococcus aureus in Canadian hospitals: 5 years of national surveillance, CMAJ, 165, 1, pp. 21-26, (2001)

[25]

Muller-Premru M., Gubina M., Epidemiological typing of methicillin-resistant Staphylococcus aureus isolates from surgical wounds and other sites of patients in the Medical Centre Ljubljana, Act Dermatoven APA, 13, 2, pp. 35-40, (2004)

[26]

Thompson R.L., Cabezudo I., Wenzel R.P., Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus, Ann Intern Med, 97, pp. 309-317, (1982)

[27]

Boyce J.M., Jackson M.M., Pugliese G., Batt M.D., Fleming D., Garner J.S., Hartstein A.I., Kauffman C.A., Simmon M., Weinstein R., Methicillin-resistant Stophylococcus aureus (MRSA): A briefing for acute care hospitals and nursing facilities, Infect Control Hosp Epidemiol, 15, pp. 105-115, (1994)

[28]

Monnet D.L., Methicillin-resistant Stophylococcus aureus and its relationship to antimicrobial use: Possible implications for control, Infect Control Hosp Epidemiol, 19, pp. 552-559, (1998)

[29]

Aires de Sousa M., Miragaia M., Sanches I.S., Avila S., Adamson I., Casagrande S.T., Brandileone M.C.A., Palacio R., Dell'Acqua I., Hortal M., Camou T., Rossi A., Velazquez-Meza M.E., Echaniz-Aviles G., Solorzano-Santos F., Heitmann I., de Lencastre H., Three-Year Assessment of Methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998, J Clin Microbiol, 39, 6, pp. 2197-2205, (2001)

[30]

Orrett F.A., Shurland S.M., Prevalence of Bacterial pathogens and susceptibility patterns from clinical sources in Trinidad, West Indian Med J, 49, 3, pp. 205-209, (2000)

← 1 2 3 4 →